Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/1151
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmith, Ren_AU
dc.contributor.authorHardy, CJen_AU
dc.contributor.authorBoyd, REen_AU
dc.date.accessioned2008-07-15T06:21:44Zen_AU
dc.date.accessioned2010-04-30T04:43:38Z-
dc.date.available2008-07-15T06:21:44Zen_AU
dc.date.available2010-04-30T04:43:38Z-
dc.date.issued1984-03en_AU
dc.identifier.citationSmith, R., Hardy C. J. & Boyd, R. E. (1984). The case for a national medical cyclotron (DR 16). Lucas Heights, NSW: Australian Atomic Energy Commission Research Establishment.-
dc.identifier.govdoc996-
dc.identifier.urihttp://apo.ansto.gov.au/dspace/handle/10238/1151en_AU
dc.description.abstractIt is proposed that a National Medical Cyclotron and associated radioisotope processing facilities be established to provide Australia and the South East Asian and Pacific Regions with the full range of radioisotopes and radiopharmaceuticals vital to the diagnosis and treatment of a wide variety of medical conditions. Specifically a national medical cyclotron would be used to produce those cyclotron-produced radioisotopes which cannot be imported because of their short half-lives (e.g. carbon-11, nitrogen-13, oxygen-15, fluorine-18, iodine-123, rubidium-81, mercury-195m), and also those of long half-life which are imported at substantial cost (about $0.75 million in 1983) on a rather unreliable basis (e.g. gallium-67, thallium-201, indium-111). These cyclotron-produced radioisotopes (with the exception of iodine-123 to replace iodine-131) are complementary to the range of reactor-produced radioisotopes available from the Australian reactor HIFAR. Where feasible in terms of radioisotope lifetime, the products from the cyclotron would be distributed Australia-wide, and also to the immediate geographical region, using the Australia AEC distribution service already available for reactor-produced products. To take full advantage of the potential medical benefits, the cyclotron would be located in NSW at a major teaching hospital, provisionally the Royal Prince Alfred Hospital, Sydney, but it would be owned and operated by the Australian Atomic Energy Commission. Installation could be completed in 1987/88 at a cost of about $10 million. Funding of $200,000 is sought in 1984/85 for the preparation of detailed plans and specifications.en_AU
dc.language.isoenen_AU
dc.publisherAustralian Atomic Energy Commissionen_AU
dc.relation.ispartofseriesAAEC-DR-16en_AU
dc.subjectCyclotronsen_AU
dc.subjectRadioisotopesen_AU
dc.subjectRadiopharmaceuticalsen_AU
dc.subjectHalf-lifeen_AU
dc.subjectHIFAR Reactoren_AU
dc.subjectAAECen_AU
dc.titleThe case for a national medical cyclotronen_AU
dc.typeExternal Reporten_AU
Appears in Collections:Scientific and Technical Reports

Files in This Item:
File Description SizeFormat 
AAEC-DR-16.pdf1.25 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.